Home LiteratureArticle Details
PMID: 384643 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial

Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.

Urology ·Vol. 14 ·No. 3 ·1979-09-00 ·Pages 233-6

Rotschafer J, Crossley K, Zaske D, Viste R

Abstract

Cefaclor or amoxicillin was given to 51 randomly assigned patients with urinary tract infections. Inclusion in the study required two pretreatment urine cultures yielding the same organism (susceptible to both antibiotics) in concentrations greater than or equal to 10(5)/ml. Both drugs were administered as 250 mg. orally every eight hours for ten days. Cefaclor was given to 27 patients and amoxicillin to 24. Most patients in both groups had negative urine cultures at five to nine days and four to six weeks following therapy. One patient in each group was unsuccessfully treated. Relapse or reinfection occurred with similar frequency in both treatment groups. Both antibiotics were well tolerated. minimal inhibiting concentrations (MICS) of cefaclor, amoxicillin, cephradine, and cephalexin were determined by an agar dilution technique for the 44 available pretreatment isolates (41 Escherichia coli and 3 Proteus mirabilis). Mean MICs (micrograms./ml., +/- SD) were 2.2 +/- 1.4 for cefaclor, 4.4 +/- 2.0 with amoxicillin, 8.1 +/- 4.2 for cephradine, and 5.7 +/- 3.0 with cephalexin. Cefaclor is highly active in vitro against those gram-negative bacteria which are commonly isolated from urine. Cefaclor is as effective as amoxicillin when administered three times daily for the treatment of urinary tract infection.

MeSH Terms
Amoxicillin/administration & dosage,therapeutic use Bacterial Infections/drug therapy Cefaclor/administration & dosage,therapeutic use Cephalexin/administration & dosage,analogs & derivatives Cephradine/administration & dosage Escherichia coli Infections/drug therapy Female Humans Male Middle Aged Proteus Infections/drug therapy Proteus mirabilis Recurrence Urinary Tract Infections/drug therapy
Chemicals
Cefaclor Amoxicillin Cephradine Cephalexin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Rotschafer J
Crossley K
Zaske D
Viste R
Article Info
Journal
Urology
Abbr.
Urology
ISSN
0090-4295
Published
1979-09-00
Pages
233-6
Language
English
Region
United States
NLM ID
0366151
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com